Persistent Asset Partners’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-649
Closed -$359K 491
2025
Q4
$359K Buy
649
+198
+44% +$4.32K 0.16% 164
2025
Q3
$171K Buy
451
+33
+8% +$472 0.12% 138
2025
Q2
$64.5K Hold
418
0.05% 139
2025
Q1
$56.9K Buy
+418
New +$5.7K 0.05% 130

Other funds holding ZYME

Persistent Asset Partners's ZYME Position: Q1 2026 in Review

Persistent Asset Partners increased its Zymeworks (ZYME) stake by 389% in Q1 2026, buying an estimated $676K and bringing the position to 35,935 shares worth $900K. The position accounts for 0.34% of the portfolio, ranked #74.

Persistent Asset Partners first reported a position in ZYME in Q4 2025 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Persistent Asset Partners held 35,935 shares of Zymeworks worth $900K as of Q1 2026.
  • Persistent Asset Partners bought 28,589 Zymeworks shares in Q1 2026, an estimated $676K.
  • Zymeworks made up 0.34% of Persistent Asset Partners's portfolio in Q1 2026, its #74 holding.
  • Persistent Asset Partners first reported a position in Zymeworks in Q4 2025 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.